Findings from this survey also demonstrated that 23% of providers were comfortable with interpreting biomarker testing ...

A new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...

Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...

A mom tested positive for fentanyl the same day her 2-year-old son died of a fentanyl and xylazine overdose, Florida ...

With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies ...

The therapy, dubbed OST-HER2, uses a HER2-bioengineered form of the bacteria Listeria monocytogenes to trigger an immune ...

T CDx is a 648-gene next-generation sequencing test for solid tumor profiling, which includes microsatellite instability status and companion diagnostic claims for colorectal cancer patients. xT CDx ...

Impacting millions of children in the U.S. alone, asthma can be particularly problematic to diagnose with specificity — ...

Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in ...

HER2DX ®️ is the world’s first diagnostic test formulated specifically for HER2+ breast cancer. Marketed by REVEAL GENOMICS ...

“The GeparOla trial included patients with early HER2-negative breast cancer who had homologous recombination deficiency, HRD ...

Kwena Maphaka became the youngest South African to make a test debut as the Proteas won the toss and elected to bat in the second and final test against Pakistan on Friday. The 18 years and 270 ...